Nurix Therapeutics: Baird raises target price to $36 from $33
NRIX•Baird raised its target price for Nurix Therapeutics to $36 from $33.
Related News
Gold ticks up as oil eases; spotlight on US inflation data
GLD•
Givaudan targets 4%-6% average like-for-like sales growth through 2030 strategy cycle
GVDNY•
Australia dollar finds some support in RBA hawks, kiwi totters
TLT•
SS&C says private credit still has room to grow, but underwriting discipline faces rising scrutiny
SSNC•
Graphic Packaging Holding Company: RBC cuts target price to $9 from $10
GPK•